MARKET

ASRT

ASRT

Assertio Holdings Inc
NASDAQ
1.140
+0.120
+11.76%
After Hours: 1.160 +0.02 +1.75% 18:42 12/01 EST
OPEN
1.030
PREV CLOSE
1.020
HIGH
1.160
LOW
1.020
VOLUME
1.12M
TURNOVER
0
52 WEEK HIGH
8.01
52 WEEK LOW
0.8700
MARKET CAP
107.92M
P/E (TTM)
-0.5556
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ASRT last week (1120-1124)?
Weekly Report · 6d ago
Assertio: Major Insider Selling Make It A Must Sell
Home healthcare assertio: major insider selling make it a must sell. The magnitude and frequency of insider sales cast doubt on the company's trajectory and erodes trust in management's statements. Deep value investing requires a robust balance sheet, catalysts, and insider activity. Insider selling in assertio raises red flags.
Seeking Alpha · 11/21 20:58
Weekly Report: what happened at ASRT last week (1113-1117)?
Weekly Report · 11/20 11:18
Assertio Holdings Inc: Current report
Press release · 11/14 14:23
Weekly Report: what happened at ASRT last week (1106-1110)?
Weekly Report · 11/13 11:11
Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Henry Schein (HSIC) and Assertio Therapeutics (ASRT)
TipRanks · 11/10 09:32
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Astra space, inc. Shares climbed 59.5% to $1.18 after astra received a non-binding proposal to acquire all of the company's stock. The honest company shares rose 23% following upbeat quarterly results. Affirm holdings shares rose 22.7% after reporting better-than-expected first-quarter results.
Benzinga · 11/09 18:13
DTCK, CDIO and MOBV among mid-day movers
On the move: inbs, atra, eva, jrvr and mobv among mid-day movers. Dtck, cdio and cdlx among the losers in the biotechnology sector. In the tech sector, intelligent bio solutions and pineapple financial were among the gainers.
Seeking Alpha · 11/09 17:48
More
About ASRT
Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients utilizing a non-personal promotional model. Its commercial portfolio of branded products focuses on three areas: neurology, rheumatology, and pain and inflammation. Its primary marketed products include INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Otrexup (methotrexate) injection for subcutaneous use, Sympazan (clobazam) oral film, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipso (diclofenac potassium) Liquid filled capsules. It also offers OXAYDO (oxycodone HCI, USP) tablets. INDOCIN (indomethacin) Suppositories are nonsteroidal anti-inflammatory drug (NSAID), indicated for moderate to severe rheumatoid arthritis, including acute flares of chronic diseases, moderate to severe ankylosing spondylitis and others. Its portfolio also includes ROLVEDON (eflapegrastim-xnst) Injection asset.

Webull offers Assertio Holdings Inc stock information, including NASDAQ: ASRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASRT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASRT stock methods without spending real money on the virtual paper trading platform.